COVID-19 has shown that pharma companies need to make their complex and inefficient global supply chains more resilient. With high-value therapeutics at stake, having a flexible, resilient, and robust manufacturing supply chain is more important than ever. Learn more about ensuring capacity, meeting global demand, and what we can expect in regard to outsourced manufacturing and the ever-evolving changes in the pharmaceutical supply chain. Join industry expert, Omair Ahmed, Chief Strategy Officer, Nexus Pharmaceuticals, to learn more.